Jeff Settleman
Genentech · 224 works · 27,670 citations · h-index 44
Top works
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
- Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
- Targeting the RAF–MEK–ERK pathway in cancer therapy
- Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
- Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
- Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- Rho family GTPases: more than simple switches
- DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis
- Drivers and passengers
- Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas
- The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis
- Reproducible pharmacogenomic profiling of cancer cell line panels
- Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers